Carl W. Fuller

Carl has been working for more than 30 years with DNA polymerases, RNA polymerases, and reverse transcriptases. He was directly involved in corporate efforts to produce complete sequencing systems such as the capillary electrophoresis system of Molecular Dynamics/Amersham, the SOLiD system of Applied Biosystems, and the chip-based sequencers of Genia and Ion Torrent. Carl has served in senior and executive-level positions at Singular Genomics, Genia Technologies (now Roche), Life Technologies, GE Healthcare, and Amersham Biosciences. He has published over 70 issued patents and patent applications.